News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Health Discovery Corporation (DWCM.OB) Issues Update on U.S. and International Developments Relating to its SVM-RFE Technology Patents


10/7/2011 9:24:44 AM

SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that it has recently received notices of allowance in two of its patent applications covering the Company’s SVM-RFE technology. The first notice was issued by the United States Patent and Trademark Office for a continuation application that was filed to further expand the scope of coverage of the RFE algorithm. The allowed claims cover all uses of the SVM-RFE algorithm, including but not limited to its use in biomarker discovery. The second notice of allowance was issued by the Canadian Intellectual Property Office for claims covering the use of SVM-RFE for biomarker discovery. Once issued, this will be the Company’s second Canadian patent covering SVM-RFE. The first patent, which issued in late 2010, like the newly allowed U.S. application, is not limited to any specific data type thereby covering all applications of the SVM-RFE technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES